Rockefeller Capital Management L.P. - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$48
-99.9%
1,2280.0%0.00%
Q3 2022$58,000
-12.1%
1,228
-28.3%
0.00%
Q2 2022$66,000
-8.3%
1,713
+35.4%
0.00%
Q1 2022$72,000
-25.8%
1,265
+3.0%
0.00%
Q4 2021$97,000
-8.5%
1,2280.0%0.00%
-100.0%
Q3 2021$106,000
-32.9%
1,2280.0%0.00%0.0%
Q2 2021$158,000
+61.2%
1,2280.0%0.00%0.0%
Q1 2021$98,000
-2.0%
1,2280.0%0.00%0.0%
Q4 2020$100,000
+426.3%
1,228
+53.5%
0.00%
Q3 2020$19,0008000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders